Novel benzimidazole-oxadiazole hybrid molecules as promising antimicrobial agents
In the present study, we describe the design and expeditious synthesis of novel 2-aryl-5-(3-aryl-[1,2,4]-oxadiazol-5-yl)-1-methyl-1H-benzo[d]imidazole hybrid molecules as promising antimicrobial agents. The core moiety 2-aryl-ethyl-1H-benzo[d]imidazole-5-
HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS
The present application relates to novel aryl compounds with heterocyclic substituents, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention
-
Paragraph 0918
(2013/08/14)
HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS
The present application relates to novel substituted aryl compounds, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.
-
Page/Page column 35
(2011/12/14)
Aryl compounds with aminoalkyl substituents and their use
The present application relates to novel aryl compounds with aminoalkyl substituents, to processes for their preparation, to their use for treatment and/or prevention of diseases and to their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.
-
Page/Page column 40-41
(2012/01/13)
NOVEL HETEROCYCLIC METHYLENE PIPERIDINE DERIVATIVES AND THEIR USE
The present invention is directed to compounds of formula (I) compositions comprising them and their use.
-
Page/Page column 96
(2009/03/07)
GPCR AGONISTS
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
-
Page/Page column 30
(2010/11/25)
HETEROCYCLIC GPCR AGONISTS
Compounds of formula (I) or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.
-
Page/Page column 23
(2008/06/13)
HETEROCYCLIC COMPOUNDS USEFUL AS DPP- IV INHIBITORS
The invention relates to compounds of formula Z-C(R1R2)-C(R3NH2)-C(R4R5)-A (I) wherein Z, R1-R5 and A have the meaning as cited in the description and the claims as examplified by the compound (II) said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
-
Page/Page column 28
(2010/10/19)
More Articles about upstream products of 56935-74-1